Nmt2 - N-myristoyltransferase 2 Gene
Also Known as hNMT-2; A930001K02Rik
Species: Mus musculus
Summary
Predicted to enable glycylpeptide N-tetradecanoyltransferase activity. Predicted to be involved in N-terminal peptidyl-glycine N-myristoylation. Predicted to act upstream of or within N-terminal protein myristoylation. Predicted to be located in Golgi apparatus; cytosol; and plasma membrane. Predicted to be extrinsic component of membrane. Predicted to be active in cytoplasm. Is expressed in early conceptus; embryo; liver; lung; and spinal cord. Orthologous to human NMT2 (N-myristoyltransferase 2). [provided by Alliance of Genome Resources, Apr 2022]
Nmt2 Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_001290368.1 | NP_001277297.1 | glycylpeptide N-tetradecanoyltransferase 2 isoform b |
| NM_001290369.1 | NP_001277298.1 | glycylpeptide N-tetradecanoyltransferase 2 isoform c |
| NM_001290370.1 | NP_001277299.1 | glycylpeptide N-tetradecanoyltransferase 2 isoform d |
| NM_008708.2 | NP_032734.1 | glycylpeptide N-tetradecanoyltransferase 2 isoform a |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
glycylpeptide N-tetradecanoyltransferase 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-112258 | IMP-1088 | Inhibitor | 98.84% | Unkown |
| HY-147308 | Zelenirstat | Inhibitor | 99.76% | Unkown |
| HY-P6028A | GSNKSKPK-NH2 TFA | Substrate | 99.91% | Unkown |
| HY-P6028 | GSNKSKPK-NH2 | Substrate | 98.00% | Unkown |
| HY-RS09390 | NMT2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18145 | Nmt2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24620 | Nmt2 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service